MONTREAL, May 21, 2026 – HPQ Silicon Inc., a technology company specializing in advanced materials and next-generation processes, announced that its French technology partner, Novacium SAS, has signed a Letter of Intent (LOI) with GH Technologies Co., Ltd. The arms-length LOI was signed on May 15, 2026, at the 18th China International Battery Fair (CIBF) and covers the supply of Novacium’s GEN4 lithium-ion cells in 18650 and 21700 formats, along with other lithium-ion batteries built on Novacium’s GEN4 silicon anode technology.
Strategic Partnership for Asia-Pacific Markets
The non-binding, non-exclusive LOI establishes a 36-month framework for commercial prospecting and potential distribution across multi-sector applications, including light electric mobility, embedded systems, and high-energy-density electronic equipment in Asia-Pacific. This region accounts for more than 57% of global demand for cylindrical lithium-ion cells. A key objective of the LOI is to evaluate potential commercial opportunities for Novacium GEN4 products in Asia-Pacific markets over the term of the agreement.
“Following an extensive evaluation of NOVACIUM GEN4 cells, including reported capacity exceeding 6,600 mAh, reported energy density of 319.9 Wh/kg, and international certifications including IEC 62133, UL 1642, and UN 38.3, GH Technologies agreed to enter into this LOI with Novacium to further evaluate potential business opportunities in Asia-Pacific markets,” stated Mr. Jacques Shen, CEO of GH Technologies Co., Ltd.
Next Steps and Regulatory Approvals
The completion of a definitive transaction remains subject to the negotiation and execution of a purchase and sale agreement, the successful technical validation of the cells by GH Technologies’ customers within their targeted applications, and the receipt of all applicable regulatory approvals.
“The signing of this LOI at CIBF supports Novacium’s ongoing efforts to evaluate potential commercial opportunities for its GEN4 battery technologies in Asia,” said Dr. Jed Kraiem, Chief Operating Officer of Novacium SAS. “The discussions with GH Technologies reflect interest in evaluating GEN4 cells for applications requiring high-capacity lithium-ion solutions.”
“This LOI provides a framework for Novacium and GH Technologies to evaluate potential business opportunities involving GEN4 battery technologies in Asia-Pacific markets,” said Bernard Tourillon, Chairman and Chief Executive Officer of HPQ Silicon Inc. “HPQ’s 36.8% equity ownership in Novacium SAS and its exclusive North American license provide the Company with access to these technologies for Canada, the United States, and Mexico under the HPQ ENDURA+ trademark.”
